A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)

Abstract SARS-CoV-2 directly targets alveolar epithelial cells and can lead to surfactant deficiency. Early reports suggested surfactant replacement may be effective in improving outcomes. The aim of the study to assess the feasibility and efficacy of nebulized surfactant in mechanically ventilated...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Ahilanandan Dushianthan, Howard W. Clark, David Brealey, Danny Pratt, James B. Fink, Jens Madsen, Helen Moyses, Lewis Matthews, Tracy Hussell, Ratko Djukanovic, Martin Feelisch, Anthony D. Postle, Michael P. W. Grocott
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Portfolio 2023-11-01
Serija:	Scientific Reports
Online dostop:	https://doi.org/10.1038/s41598-023-47672-x
Oznake:	Označite Brez oznak, prvi označite!